NF2 and mesothelioma: Another study showed that defactinib sensitivity using mesothelioma cell lines was not related to inactivating NF2 mutations or protein expression of merlin, but was strongly correlated with FAK activity, especially in epithelioid mesothelioma (Tranchant et al., 2018).